Unternehmen GreenLight Biosciences Holdings
Aktien
GRNA
US39536G1058
GRNA
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24.07.23 |
Drew Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Amin Khan
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Nina Thayer
CMP | Compliance Officer | - | 01.03.23 |
Carole Cobb
COO | Chief Operating Officer | 66 | - |
Thomas Crampton
PRN | Corporate Officer/Principal | - | - |
Mark Singleton
PRN | Corporate Officer/Principal | 56 | - |
Charu Manocha
HRO | Human Resources Officer | 57 | 01.01.20 |
Corporate Officer/Principal | 51 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24.07.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 151 681 314 | 119 177 217 ( 78,57 %) | 0 | 78,57 % |
Unternehmenskontakt
GreenLight Biosciences Holdings PBC
29 Hartwell Avenue
02421, Lexington
+
http://www.greenlightbiosciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+1,51 % | 42,75 Mrd. | |
+49,22 % | 41,61 Mrd. | |
+8,57 % | 41,34 Mrd. | |
-12,36 % | 26,59 Mrd. | |
+8,92 % | 25,49 Mrd. | |
-25,13 % | 18,12 Mrd. | |
+29,17 % | 12,24 Mrd. | |
-3,12 % | 11,76 Mrd. | |
+6,35 % | 11 Mrd. |